These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31132076)

  • 1. Elevated serum concentrations of IGF-1 and IGF-1R in patients with thyroid cancers.
    Lawnicka H; Motylewska E; Borkowska M; Kuzdak K; Siejka A; Swietoslawski J; Stepien H; Stepien T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):77-83. PubMed ID: 31132076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and significance of IGF-1 and IGF-1R in thyroid nodules.
    Liu YJ; Qiang W; Shi J; Lv SQ; Ji MJ; Shi BY
    Endocrine; 2013 Aug; 44(1):158-64. PubMed ID: 23288662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration in the serum concentrations of FGF19, FGFR4 and βKlotho in patients with thyroid cancer.
    Motylewska E; Stępień T; Borkowska M; Kuzdak K; Siejka A; Komorowski J; Stępień H; Ławnicka H
    Cytokine; 2018 May; 105():32-36. PubMed ID: 29438906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Concentrations of SERPINE2/Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer.
    Stępień T; Brożyna M; Kuzdak K; Motylewska E; Komorowski J; Stępień H; Ławnicka H
    Dis Markers; 2017; 2017():4962137. PubMed ID: 28255192
    [No Abstract]   [Full Text] [Related]  

  • 5. Low level of plasma fibulin-1 in patients with thyroid lesions: a case-control study and literature review.
    Hedayati M; Abooshahab R; Razavi SA; Salehipour P; Ahmadikia K; Boroomand S
    Mol Biol Rep; 2020 Nov; 47(11):8859-8866. PubMed ID: 33106982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.
    Yu H; Huang X; Liu X; Jin H; Zhang G; Zhang Q; Yu J
    Endocrine; 2013 Aug; 44(1):172-81. PubMed ID: 23264145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary Thyroid Cancer and Coexisting Autoimmune Thyroiditis.
    Veit F; Graf D; Momberger S; Helmich-Kapp B; Ruschenburg I; Peters A; Kussmann J; Saeger W; Schmidt KW; Toetsch M; Nestler K; Mann K
    Horm Metab Res; 2017 Nov; 49(11):869-872. PubMed ID: 29136676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers?
    Razavi SA; Modarressi MH; Yaghmaei P; Tavangar SM; Hedayati M
    Endocrine; 2017 Sep; 57(3):428-435. PubMed ID: 28755140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between Serum Inflammatory Factor Levels and Differentiated Thyroid Carcinoma.
    Zhang X; Li S; Wang J; Liu F; Zhao Y
    Technol Cancer Res Treat; 2021; 20():1533033821990055. PubMed ID: 33752541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis.
    Zhu C; Dai Y; Zhang H; Ruan Y; Zhou Y; Dai Y; Fan L; Jia T; Lu H; Chen Q
    Diagn Pathol; 2021 Aug; 16(1):84. PubMed ID: 34465342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?
    Ria R; Prete F; Melaccio A; Di Meo G; Saltarella I; Solimando AG; Gurrado A; Ferraro V; Pasculli A; Sgaramella LI; Racanelli V; Vacca A; Testini M
    Surgery; 2021 Jan; 169(1):27-33. PubMed ID: 32482341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Vitamin D, Platelet-Derived Growth Factor and Insulin-Like Growth Factor 1 in the Progression of Thyroid Diseases.
    Abdellateif MS; Shaarawy S; Elesawy YF; Mansour M; Tharwat E; Ibrahim NH; Eissa MS
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2083-2089. PubMed ID: 32711436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression characteristics of proteins of IGF-1R, p-Akt, and survivin in papillary thyroid carcinoma patients with type 2 diabetes mellitus.
    Yan Y; Hu F; Wu W; Ma R; Huang H
    Medicine (Baltimore); 2017 Mar; 96(12):e6393. PubMed ID: 28328831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation in IGF-1R, FGFR4 and βKlotho signaling in patients with medullary thyroid cancer.
    Motylewska E; Borkowska M; Ławnicka H; Kuzdak K; Siejka A; Świętosławski J; Stepien H; Stepien T
    Neuro Endocrinol Lett; 2019 Mar; 40(1):29-35. PubMed ID: 31184820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma.
    Jin J; Wu G; Ruan C; Ling H; Zheng X; Ying C; Zhang Y
    J Clin Lab Anal; 2022 Jun; 36(6):e24443. PubMed ID: 35441746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SERUM ADIPONECTIN AND INSULIN-LIKE GROWTH FACTOR 1 IN PREDOMINANTLY FEMALE PATIENTS WITH THYROID CANCER: ASSOCIATION WITH THE HISTOLOGIC CHARACTERISTICS OF THE TUMOR.
    Pazaitou-Panayiotou K; Panagiotou G; Polyzos SA; Mantzoros CS
    Endocr Pract; 2016 Jan; 22(1):68-75. PubMed ID: 26484409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
    Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
    [No Abstract]   [Full Text] [Related]  

  • 19. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
    Hou X; Jiang L; Chen C; Zhu X; Ge M
    Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter.
    Tollin SR; Mery GM; Jelveh N; Fallon EF; Mikhail M; Blumenfeld W; Perlmutter S
    Thyroid; 2000 Mar; 10(3):235-41. PubMed ID: 10779138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.